Please let us know where you are, or where you would like to be in the world so we can point you in the right direction.

Daniel Couto is the COO of Vedanta Biosciences, a leading microbiome company who recently completed $68 Million Series D Financing. Dan has nearly 30 years of experience starting and advancing biopharmaceutical development and manufacturing organizations to higher levels of capability, growth and productivity.

Vedanta is developing a novel class of therapies that modulate pathways of interaction between the human microbiome and the host immune system.

Share